LCTX - Lineage Cell Therapeutics GAAP EPS of -$0.03 in-line revenue of $2.1M misses by $0.74M
2024-03-07 16:09:45 ET
More on Lineage Cell Therapeutics
- Lineage Cell Therapeutics: Not Yet Attractive Stem Cell Company
- Seeking Alpha’s Quant Rating on Lineage Cell Therapeutics
- Historical earnings data for Lineage Cell Therapeutics
- Financial information for Lineage Cell Therapeutics